BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9259828)

  • 21. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
    Kjeldsen-Kragh J; Titze TL; Lie BA; Vaage JT; Kjær M
    Blood Adv; 2019 Apr; 3(7):945-951. PubMed ID: 30923048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.
    Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B
    J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo.
    Di Cristofaro J; Frassati C; Montagnie R; Basire A; Merieux Y; Picard C
    Platelets; 2015; 26(5):421-4. PubMed ID: 25101933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetomaternal alloimmune thrombocytopenia.
    Ahya R; Turner ML; Urbaniak SJ;
    Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DRB3 typing by restriction digestion of locus-specific amplified DNA.
    Smrzka OW; Faé I; Pickl WF; Fischer GF
    Tissue Antigens; 1991 May; 37(5):205-10. PubMed ID: 1685265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The platelet-specific alloantigen PlA1 (HPA-1a): a comparison of flow cytometric immunophenotyping and genotyping using polymerase chain reaction and restriction fragment length polymorphism in a Swedish blood donor population.
    Forsberg B; Jacobsson S; Stockelberg D; Kutti J; Rydberg L; Wadenvik H
    Transfusion; 1995 Mar; 35(3):241-6. PubMed ID: 7878717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid DNA typing for class II HLA antigens: subtyping of DRw52-associated DRB1 alleles.
    Horne C; Keown PA
    Tissue Antigens; 1993 May; 41(5):243-8. PubMed ID: 7901922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.
    Valentin N; Gagne K; Kerdudou N; Hallé L; Kaplan C; Killie MK; Skogen B; Muller JY; Bignon JD
    Transfusion; 2007 Dec; 47(12):2322-9. PubMed ID: 17714418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.
    Kjær M; Tiller H; Heide G; Kjeldsen-Kragh J; Skogen B; Husebekk A
    PLoS One; 2017; 12(8):e0182957. PubMed ID: 28837581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloimmunization against the platelet-specific Zwa antigen, resulting in neonatal alloimmune thrombocytopenia or posttransfusion purpura, is associated with the supertypic DRw52 antigen including DR3 and DRw6.
    de Waal LP; van Dalen CM; Engelfriet CP; von dem Borne AE
    Hum Immunol; 1986 Sep; 17(1):45-53. PubMed ID: 3488986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
    Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
    Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.
    Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S
    Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
    Jeremiah ZA; Atiegoba AI; Mgbere O
    Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland.
    Davoren A; McParland P; Crowley J; Barnes A; Kelly G; Murphy WG
    BJOG; 2003 May; 110(5):492-6. PubMed ID: 12742334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
    Lucas G; Culliford S; Green F; Sidra G; Calvert A; Green A; Harrison P; Harvey J; Allen D; Smillie D; Masurekar A; Marks D; Russell N; Massey E
    Transfusion; 2010 Feb; 50(2):334-9. PubMed ID: 19874563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.
    Nomura S; Matsuzaki T; Yamaoka M; Ozaki Y; Nagahama M; Yoshimura C; Kagawa H; Nakayama S; Fukuhara S
    Autoimmunity; 1999; 30(2):99-105. PubMed ID: 10435723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
    Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
    Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.